Covered recipient · General Payments record
MICHAEL GAGE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2022
$399.83
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $399.83 | 15 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $119.87 | 5 |
| Esperion Therapeutics, Inc. | $93.05 | 1 |
| Novo Nordisk AS | $61.26 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.87 | 1 |
| SANOFI-AVENTIS U.S. LLC | $24.80 | 1 |
| MannKind Corporation | $23.81 | 1 |
| Amgen Inc. | $20.02 | 1 |
| Antares Pharma, Inc. | $19.97 | 1 |
| Corcept Therapeutics | $12.18 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2022 | $399.83 | 15 |
Payment records · PY2022 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.02 | 09/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939650025 | CMS |
| Antares Pharma, Inc. | $19.97 | 07/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956921937 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.87 | 09/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 887629213 | CMS |
| Corcept Therapeutics | $12.18 | 09/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 948813389 | CMS |
| Esperion Therapeutics, Inc. | $93.05 | 07/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 947301357 | CMS |
| Lilly USA, LLC | $28.36 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918589099 | CMS |
| Lilly USA, LLC | $32.06 | 04/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918607205 | CMS |
| Lilly USA, LLC | $24.97 | 06/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918660697 | CMS |
| Lilly USA, LLC | $14.94 | 08/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918617831 | CMS |
| Lilly USA, LLC | $19.54 | 08/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918660701 | CMS |
| Mannkind Corporation | $23.81 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 942772471 | CMS |
| Novo Nordisk Inc | $17.91 | 05/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899352917 | CMS |
| Novo Nordisk Inc | $24.95 | 08/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898776867 | CMS |
| Novo Nordisk Inc | $18.40 | 08/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899672565 | CMS |
| SANOFI-AVENTIS U.S. LLC | $24.80 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939147649 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022
- Source files
- Dataset page · Bulk file · PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.